AOD-9604 works in the body on adipose tissue, also known as body fat tissue
If you are taking prescription medication, have a medical condition, or are pregnant or nursing, consult your physician prior to use
The amount of active ingredient in the final formulation ranges from 0.1 to 5.0%
(River Peptides) Thus FOXO4-DRI belongs to the next generation of senolytic tools with improved selectivity and lower collateral damage risk (at least in preclinical models)
Peptide therapy is a broader category of compounded peptides used to support recovery, sleep, cognition, body composition, skin health, or healthy aging (e.g., CJC-1295/Ipamorelin for growth hormone signaling, BPC-157 for soft-tissue support)
Each product is accompanied by a certificate of analysis (CoA) with full qualitative test results